A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis
Purpose: Xiang-Sha-Liu-Jun-Zi-Tang(XSLJZT) is a common formula for the treatment of Gastric Cancer(GC) and is widely used in clinical practice, however, there is a lack of investigation into its mechanism. Methods: We collected and organized drug and disease targets, constructed the “XSLJZT-Active I...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023067543 |
| _version_ | 1797669816056676352 |
|---|---|
| author | Ke Jiang Heli Liu Jie Ge Bo Yang Yu Wang Wenbo Wang Yuqi Wen Siqing Zeng Quan Chen Jun Huang Xingui Xiong |
| author_facet | Ke Jiang Heli Liu Jie Ge Bo Yang Yu Wang Wenbo Wang Yuqi Wen Siqing Zeng Quan Chen Jun Huang Xingui Xiong |
| author_sort | Ke Jiang |
| collection | DOAJ |
| description | Purpose: Xiang-Sha-Liu-Jun-Zi-Tang(XSLJZT) is a common formula for the treatment of Gastric Cancer(GC) and is widely used in clinical practice, however, there is a lack of investigation into its mechanism. Methods: We collected and organized drug and disease targets, constructed the “XSLJZT-Active Ingredient-Target” visualization network, and performed GO and KEGG functional enrichment analysis of crossover genes, followed by molecular docking of active ingredients and core targets. The best docked monomers were combined with weighted gene co-expression network analysis(WGCNA) and macroscopically analyzed by GO and KEGG enrichment techniques. The results of cluster gene difference analysis, ROC evaluation, and CIBERSORT immune infiltration analysis were evaluated and finally supported by cellular experiments. Results: The main components of XSLJZT are quercetin, stigmasterol, and naringenin, effectively treat GC by targeting STAT3, TP53 and MAPK3, which are involved in IL-17, TNF and HIF-1 signaling pathways. The results of molecular docking showed that quercetin bound better to the core targets. We performed an in-depth analysis of this monomer and found that quercetin acts on the core targets of TP53, MMP9, TIMP1 and MYC, and is involved in two key signaling pathways, TNF and IL-17, thus effectively treating GC. The experimental results are consistent with our analysis that quercetin inhibits the proliferation of GC cells and promotes apoptosis, and TP53, MYC and TIMP1 are the quercetin targets for the treatment of GC. Conclusion: The present study tentatively suggests that quercetin, the main active ingredient in XSLJZT, can exert a therapeutic effect on GC by targeting TIMP1. |
| first_indexed | 2024-03-11T20:50:15Z |
| format | Article |
| id | doaj.art-14c0dc908800400d93c456437d7aaa5d |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-03-11T20:50:15Z |
| publishDate | 2023-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-14c0dc908800400d93c456437d7aaa5d2023-10-01T06:00:04ZengElsevierHeliyon2405-84402023-09-0199e19546A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysisKe Jiang0Heli Liu1Jie Ge2Bo Yang3Yu Wang4Wenbo Wang5Yuqi Wen6Siqing Zeng7Quan Chen8Jun Huang9Xingui Xiong10Institute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, 410008, PR ChinaDepartment of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR ChinaInstitute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China; NATCM Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; Hunan Key Laboratory of TCM Gan, Xiangya Hospital, Central South University, Changsha, 410008, PR China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR China; Corresponding author. Institute of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University, Changsha, 410008, PR China.Purpose: Xiang-Sha-Liu-Jun-Zi-Tang(XSLJZT) is a common formula for the treatment of Gastric Cancer(GC) and is widely used in clinical practice, however, there is a lack of investigation into its mechanism. Methods: We collected and organized drug and disease targets, constructed the “XSLJZT-Active Ingredient-Target” visualization network, and performed GO and KEGG functional enrichment analysis of crossover genes, followed by molecular docking of active ingredients and core targets. The best docked monomers were combined with weighted gene co-expression network analysis(WGCNA) and macroscopically analyzed by GO and KEGG enrichment techniques. The results of cluster gene difference analysis, ROC evaluation, and CIBERSORT immune infiltration analysis were evaluated and finally supported by cellular experiments. Results: The main components of XSLJZT are quercetin, stigmasterol, and naringenin, effectively treat GC by targeting STAT3, TP53 and MAPK3, which are involved in IL-17, TNF and HIF-1 signaling pathways. The results of molecular docking showed that quercetin bound better to the core targets. We performed an in-depth analysis of this monomer and found that quercetin acts on the core targets of TP53, MMP9, TIMP1 and MYC, and is involved in two key signaling pathways, TNF and IL-17, thus effectively treating GC. The experimental results are consistent with our analysis that quercetin inhibits the proliferation of GC cells and promotes apoptosis, and TP53, MYC and TIMP1 are the quercetin targets for the treatment of GC. Conclusion: The present study tentatively suggests that quercetin, the main active ingredient in XSLJZT, can exert a therapeutic effect on GC by targeting TIMP1.http://www.sciencedirect.com/science/article/pii/S2405844023067543XSLJZTGCNetwork PharmacologyMolecular DockingWGCNAMechanism of action |
| spellingShingle | Ke Jiang Heli Liu Jie Ge Bo Yang Yu Wang Wenbo Wang Yuqi Wen Siqing Zeng Quan Chen Jun Huang Xingui Xiong A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis Heliyon XSLJZT GC Network Pharmacology Molecular Docking WGCNA Mechanism of action |
| title | A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis |
| title_full | A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis |
| title_fullStr | A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis |
| title_full_unstemmed | A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis |
| title_short | A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis |
| title_sort | study related to the treatment of gastric cancer with xiang sha liu jun zi tang based on network analysis |
| topic | XSLJZT GC Network Pharmacology Molecular Docking WGCNA Mechanism of action |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023067543 |
| work_keys_str_mv | AT kejiang astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT heliliu astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT jiege astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT boyang astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT yuwang astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT wenbowang astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT yuqiwen astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT siqingzeng astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT quanchen astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT junhuang astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT xinguixiong astudyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT kejiang studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT heliliu studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT jiege studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT boyang studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT yuwang studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT wenbowang studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT yuqiwen studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT siqingzeng studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT quanchen studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT junhuang studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis AT xinguixiong studyrelatedtothetreatmentofgastriccancerwithxiangshaliujunzitangbasedonnetworkanalysis |